Article
Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute
1 Nov 2023
Abstract excerpt
For individuals living with debilitating hereditary diseases, therapies that can modify a person’s genome (genomic therapies) hold the promise to shift treatment outlooks from a lifetime of chronic disease management to a cure [ 1 ]. We now have groundbreaking therapies for multiple disorders, including genetic eye diseases, spinal muscular atrophy, and beta-thalassemia (Table 1 ). Additional genomic therapies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
